Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.

Autor: Schwartzberg LS; West Cancer Center, Germantown, Tennessee, USA., Bhat G; Spectrum Pharmaceuticals, Inc., Irvine, California, USA., Peguero J; Oncology Consultants PA, Houston, Texas, USA., Agajanian R; The Oncology Institute of Hope and Innovation, Downey, California, USA., Bharadwaj JS; Pacific Cancer Medical Center, Anaheim, California, USA., Restrepo A; Texas Oncology PA, McAllen, Texas, USA., Hlalah O; Bond Clinic PA, Winter Haven, Florida, USA., Mehmi I; City of Hope Comprehensive Cancer Center, Simi Valley, California, USA., Chawla S; Spectrum Pharmaceuticals, Inc., Irvine, California, USA., Hasal SJ; Spectrum Pharmaceuticals, Inc., Irvine, California, USA., Yang Z; Spectrum Pharmaceuticals, Inc., Irvine, California, USA., Cobb PW; St. Vincent Frontier Cancer Center, Billings, Montana, USA.

Publikováno v: The oncologist [Oncologist] 2020 Aug; Vol. 25 (8), pp. e1233-e1241. Date of Electronic Publication: 2020 Jun 16.

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.

Autor: Robichaux JP; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Elamin YY; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Vijayan RSK; Institute for Applied Cancer Science, MD Anderson Cancer Center, Houston, TX 77030, USA., Nilsson MB; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Hu L; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., He J; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang F; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Pisegna M; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Poteete A; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Sun H; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Li S; Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA., Chen T; Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA., Han H; Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA., Negrao MV; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Ahnert JR; Investigative Cancer Therapeutics, MD Anderson Cancer Center, Houston, TX 77030, USA., Diao L; Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX 77030, USA., Wang J; Department of Hematopathology, MD Anderson Cancer Center, Houston, TX 77030, USA., Le X; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Meric-Bernstam F; Investigative Cancer Therapeutics, MD Anderson Cancer Center, Houston, TX 77030, USA., Routbort M; Department of Hematopathology, MD Anderson Cancer Center, Houston, TX 77030, USA., Roeck B; Spectrum Pharmaceuticals, Irvine, CA 92618, USA., Yang Z; Spectrum Pharmaceuticals, Irvine, CA 92618, USA., Raymond VM; Guardant Health, Inc., Redwood City, CA 94063, USA., Lanman RB; Guardant Health, Inc., Redwood City, CA 94063, USA., Frampton GM; Foundation Medicine, Cambridge, MA 02141, USA., Miller VA; Foundation Medicine, Cambridge, MA 02141, USA., Schrock AB; Foundation Medicine, Cambridge, MA 02141, USA., Albacker LA; Foundation Medicine, Cambridge, MA 02141, USA., Wong KK; Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA., Cross JB; Institute for Applied Cancer Science, MD Anderson Cancer Center, Houston, TX 77030, USA., Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jheymach@mdanderson.org.

Publikováno v: Cancer cell [Cancer Cell] 2019 Oct 14; Vol. 36 (4), pp. 444-457.e7. Date of Electronic Publication: 2019 Oct 03.